In castration-resistant prostate cancer (CRPC), PTEN/p53-deficient tumors are dependent on cholesterol metabolism and upregulate SQLE by activating SREBP2 transcription to satisfy the cholesterol demand of tumor cells and promote the growth and progression of CRPC (Shangguan et al., 2022). Here, PTEN is linked to neoplasm.